Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Scott Berkowitz

Concepts (394)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Rivaroxaban
115
2026
270
10.590
Why?
Factor Xa Inhibitors
74
2026
195
5.660
Why?
Aspirin
52
2026
405
4.410
Why?
Anticoagulants
79
2026
746
4.400
Why?
Stroke
69
2024
1287
4.030
Why?
Peripheral Arterial Disease
32
2026
507
3.620
Why?
Platelet Aggregation Inhibitors
51
2026
499
3.560
Why?
Warfarin
42
2024
179
3.430
Why?
Atrial Fibrillation
44
2024
560
3.230
Why?
Hemorrhage
63
2026
825
2.800
Why?
Intracranial Embolism
17
2021
34
2.300
Why?
Morpholines
28
2024
130
2.220
Why?
Thiophenes
27
2024
117
2.190
Why?
Venous Thromboembolism
16
2022
332
2.020
Why?
Embolism
17
2021
49
1.560
Why?
Double-Blind Method
64
2026
2070
1.400
Why?
Risk Adjustment
3
2020
86
1.370
Why?
Arthroplasty, Replacement, Hip
9
2020
193
1.340
Why?
Lower Extremity
16
2026
453
1.300
Why?
Drug Monitoring
7
2021
399
1.250
Why?
Endovascular Procedures
7
2026
390
1.170
Why?
Myocardial Infarction
21
2024
1215
1.130
Why?
Fibrinolytic Agents
12
2026
303
1.080
Why?
Thrombosis
5
2026
398
1.050
Why?
Vitamin K
15
2017
46
1.030
Why?
Drug Therapy, Combination
33
2026
1036
1.000
Why?
Coronary Artery Disease
10
2024
751
0.960
Why?
Arthroplasty, Replacement, Knee
13
2020
385
0.900
Why?
Aged
116
2026
26432
0.870
Why?
Brain Ischemia
9
2022
362
0.870
Why?
Treatment Outcome
76
2026
11821
0.860
Why?
Enoxaparin
13
2020
68
0.800
Why?
Heparin
15
2003
247
0.780
Why?
Coronary Disease
12
2021
380
0.740
Why?
Thromboembolism
8
2020
129
0.740
Why?
Venous Thrombosis
12
2020
199
0.710
Why?
Thrombolytic Therapy
7
2017
165
0.680
Why?
Vascular Surgical Procedures
6
2026
352
0.680
Why?
Brain Infarction
5
2021
23
0.670
Why?
Platelet Glycoprotein GPIIb-IIIa Complex
9
2002
25
0.630
Why?
Thrombocytopenia
11
2003
206
0.610
Why?
Middle Aged
88
2026
36619
0.610
Why?
Postoperative Complications
8
2024
3034
0.600
Why?
Humans
177
2026
146342
0.590
Why?
Male
122
2026
73396
0.590
Why?
Ischemia
8
2024
421
0.570
Why?
Female
119
2026
79499
0.550
Why?
Blood Coagulation
10
2026
267
0.540
Why?
Administration, Oral
25
2021
872
0.520
Why?
Drug-Related Side Effects and Adverse Reactions
1
2020
266
0.520
Why?
Risk Assessment
19
2024
3712
0.500
Why?
Risk Factors
41
2026
10921
0.490
Why?
Angioplasty, Balloon, Coronary
8
2003
156
0.450
Why?
Cardiovascular Diseases
9
2021
2219
0.430
Why?
Immunoglobulin Fab Fragments
7
2002
55
0.430
Why?
Prothrombin Time
5
2020
32
0.420
Why?
Pulmonary Embolism
9
2020
246
0.410
Why?
Dose-Response Relationship, Drug
18
2021
2022
0.410
Why?
Blood Transfusion
4
2014
394
0.400
Why?
Drug Administration Schedule
16
2021
790
0.360
Why?
Biomarkers, Pharmacological
3
2020
26
0.360
Why?
Secondary Prevention
8
2025
248
0.350
Why?
Cerebral Hemorrhage
3
2021
125
0.340
Why?
Aged, 80 and over
25
2026
8391
0.320
Why?
Surgical Wound Infection
1
2014
349
0.310
Why?
Azetidines
6
2005
45
0.300
Why?
Angina, Unstable
5
2003
83
0.300
Why?
Recurrence
11
2021
1133
0.290
Why?
Plaque, Atherosclerotic
2
2020
60
0.280
Why?
Heart Valve Prosthesis Implantation
2
2001
197
0.280
Why?
Time Factors
18
2026
7109
0.270
Why?
Antibodies, Monoclonal
9
2002
1512
0.270
Why?
Randomized Controlled Trials as Topic
13
2024
1763
0.260
Why?
Models, Statistical
3
2020
669
0.260
Why?
Prognosis
6
2021
4351
0.250
Why?
Vascular Diseases
2
2021
252
0.240
Why?
Incidence
11
2021
2936
0.240
Why?
Gastrointestinal Hemorrhage
2
2019
134
0.240
Why?
Platelet Aggregation
3
2002
99
0.230
Why?
Atherosclerosis
2
2019
410
0.220
Why?
Kaplan-Meier Estimate
9
2021
970
0.220
Why?
Hemostasis
1
2026
100
0.220
Why?
Aortic Valve Insufficiency
2
2016
43
0.220
Why?
Mitral Valve Insufficiency
2
2016
69
0.210
Why?
Follow-Up Studies
14
2020
5439
0.210
Why?
International Normalized Ratio
5
2018
55
0.210
Why?
Diabetes Mellitus
5
2021
1101
0.200
Why?
Internationality
6
2021
156
0.200
Why?
Proportional Hazards Models
9
2021
1331
0.200
Why?
von Willebrand Factor
5
1993
84
0.200
Why?
Anti-Arrhythmia Agents
2
2015
144
0.200
Why?
Arteries
2
2022
261
0.190
Why?
Intention to Treat Analysis
7
2021
78
0.190
Why?
Clinical Trials as Topic
7
2026
1064
0.190
Why?
Chemoprevention
2
2020
91
0.190
Why?
Myocardial Ischemia
3
2000
286
0.190
Why?
Platelet Function Tests
2
2002
37
0.190
Why?
Antifibrinolytic Agents
2
2014
68
0.180
Why?
Withholding Treatment
2
2021
77
0.180
Why?
Acute Coronary Syndrome
2
2019
299
0.180
Why?
Postoperative Care
2
2003
301
0.180
Why?
Drug Carriers
1
2003
138
0.180
Why?
Renal Insufficiency
2
2021
173
0.180
Why?
Electrocardiography
4
2001
667
0.180
Why?
Carotid Artery Diseases
2
2019
70
0.180
Why?
Echocardiography, Transesophageal
2
2019
132
0.170
Why?
Multimorbidity
1
2022
65
0.170
Why?
Drug-Eluting Stents
1
2021
88
0.170
Why?
Drug Substitution
3
2021
62
0.160
Why?
Heart Valves
1
2001
44
0.160
Why?
Therapeutic Index
1
2020
3
0.160
Why?
Intracranial Arteriosclerosis
1
2020
8
0.160
Why?
Paclitaxel
1
2021
260
0.160
Why?
Troponin T
1
2020
63
0.150
Why?
Thrombin
4
2014
175
0.150
Why?
Intracranial Hemorrhages
4
2019
106
0.150
Why?
Clinical Trials, Phase III as Topic
5
2019
116
0.150
Why?
Thrombophlebitis
2
1997
12
0.140
Why?
Tyrosine
1
2000
217
0.140
Why?
Partial Thromboplastin Time
5
2014
53
0.140
Why?
Comorbidity
6
2021
1665
0.140
Why?
Point-of-Care Systems
2
2014
185
0.140
Why?
Foramen Ovale, Patent
1
2018
11
0.140
Why?
Kidney
2
2017
1498
0.140
Why?
Emigrants and Immigrants
1
2021
160
0.140
Why?
Cardiomegaly
1
2020
175
0.140
Why?
Peptide Fragments
5
2003
693
0.140
Why?
Ischemic Attack, Transient
2
2018
71
0.140
Why?
Coronary Thrombosis
3
2016
25
0.130
Why?
Polypharmacy
2
2016
94
0.130
Why?
Heart Diseases
1
2021
343
0.130
Why?
Antigens
1
1999
350
0.130
Why?
Heart Failure
6
2021
2329
0.130
Why?
Prospective Studies
12
2021
8123
0.120
Why?
Brain
2
2020
2991
0.120
Why?
Surgery, Oral
1
1996
7
0.120
Why?
Aorta, Thoracic
1
2019
284
0.120
Why?
Orthodontic Appliances
1
1996
12
0.120
Why?
Drug Discovery
2
2015
154
0.120
Why?
Body Mass Index
3
2021
2458
0.120
Why?
Calcium Channel Blockers
1
2017
165
0.120
Why?
Prodrugs
4
2005
54
0.120
Why?
Angioplasty, Balloon
1
1997
92
0.120
Why?
Antibodies, Monoclonal, Humanized
2
2020
992
0.120
Why?
Overweight
1
2021
614
0.110
Why?
Cleft Lip
1
1996
73
0.110
Why?
Prevalence
5
2021
2861
0.110
Why?
Cleft Palate
1
1996
91
0.110
Why?
Neoplasms
3
2020
2954
0.110
Why?
Age Factors
5
2026
3347
0.110
Why?
Multivariate Analysis
6
2016
1543
0.110
Why?
Digoxin
1
2015
27
0.110
Why?
Factor X
1
2014
26
0.110
Why?
Limb Salvage
2
2026
74
0.110
Why?
Prothrombin
1
2014
25
0.110
Why?
Factor VII
1
2014
24
0.110
Why?
Severity of Illness Index
6
2021
2921
0.100
Why?
Factor IX
1
2014
49
0.100
Why?
Cognitive Dysfunction
1
2020
481
0.100
Why?
Amiodarone
1
2014
31
0.100
Why?
Cognition Disorders
1
2018
559
0.100
Why?
Blood Coagulation Factors
1
2014
71
0.100
Why?
Cardiovascular Agents
1
2015
165
0.100
Why?
Recombinant Proteins
4
2015
1361
0.100
Why?
Biomarkers
3
2020
4340
0.100
Why?
Models, Biological
2
2019
1761
0.100
Why?
Defibrillators, Implantable
1
2017
393
0.100
Why?
Arthroplasty, Replacement, Ankle
1
2012
11
0.090
Why?
Mortality
3
2021
375
0.090
Why?
Hematoma
1
2013
62
0.090
Why?
Adult
17
2020
41087
0.090
Why?
Elective Surgical Procedures
1
2014
216
0.090
Why?
Hirudins
2
2003
52
0.090
Why?
Sex Factors
4
2021
2107
0.090
Why?
von Willebrand Diseases
2
1990
28
0.090
Why?
Survival Rate
5
2020
2092
0.090
Why?
Heparin, Low-Molecular-Weight
2
2005
37
0.080
Why?
Depression
1
2021
1575
0.080
Why?
Delivery of Health Care, Integrated
1
2014
305
0.080
Why?
Percutaneous Coronary Intervention
1
2016
550
0.080
Why?
Continuity of Patient Care
1
2013
298
0.080
Why?
Peptides
4
2002
992
0.080
Why?
Acute Disease
6
2021
1038
0.080
Why?
Latin America
2
2021
96
0.080
Why?
Predictive Value of Tests
4
2021
2113
0.080
Why?
Benzylamines
6
2005
44
0.080
Why?
Factor Xa
3
2015
36
0.080
Why?
Retrospective Studies
10
2018
17438
0.070
Why?
Quality of Life
1
2022
3200
0.070
Why?
Chemical and Drug Induced Liver Injury
1
2011
138
0.070
Why?
Mental Health Services
1
2014
450
0.070
Why?
Tissue Plasminogen Activator
3
2022
245
0.070
Why?
Obesity, Morbid
1
2013
287
0.070
Why?
Single-Blind Method
2
2020
313
0.070
Why?
Sialic Acids
1
1988
8
0.070
Why?
Platelet Count
3
1998
95
0.070
Why?
Multicenter Studies as Topic
3
2018
417
0.070
Why?
Pancreatic Elastase
1
1988
54
0.070
Why?
Hospitalization
2
2016
2475
0.070
Why?
Calpain
1
1988
61
0.070
Why?
Injections, Subcutaneous
4
2010
170
0.070
Why?
Magnetic Resonance Imaging
4
2021
3926
0.070
Why?
Peptide Hydrolases
1
1988
105
0.070
Why?
Logistic Models
4
2021
2126
0.070
Why?
Platelet Transfusion
2
1999
76
0.060
Why?
Anti-Inflammatory Agents, Non-Steroidal
2
2021
344
0.060
Why?
Hypertension
1
2016
1272
0.060
Why?
Obesity
1
2021
3131
0.060
Why?
Drug Approval
2
2015
94
0.060
Why?
International Cooperation
2
2018
193
0.060
Why?
Magnetic Resonance Angiography
2
2019
249
0.060
Why?
United States Food and Drug Administration
2
2015
208
0.060
Why?
Child
6
2026
22693
0.060
Why?
Infant
4
2026
10114
0.060
Why?
Chronic Disease
2
2025
1827
0.060
Why?
Cohort Studies
3
2022
6077
0.060
Why?
Drug Combinations
2
2019
400
0.060
Why?
Infusions, Intravenous
2
1998
432
0.060
Why?
Europe
2
2019
421
0.060
Why?
Child, Preschool
4
2026
11913
0.060
Why?
Adolescent
8
2020
22557
0.060
Why?
Infant, Newborn
3
2026
6460
0.060
Why?
Preoperative Care
2
2020
396
0.060
Why?
Combined Modality Therapy
2
2020
1271
0.050
Why?
Purinergic P2Y Receptor Antagonists
2
2018
71
0.050
Why?
Creatinine
2
2017
511
0.050
Why?
Forecasting
2
2013
388
0.050
Why?
Safety
3
2000
347
0.050
Why?
Pharmacokinetics
1
2003
33
0.050
Why?
Caprylates
1
2003
21
0.050
Why?
Body Weight
2
1998
968
0.050
Why?
Angiography
1
2024
206
0.050
Why?
United States
5
2019
16136
0.050
Why?
Cause of Death
2
2016
456
0.050
Why?
Myocardial Revascularization
2
2000
85
0.050
Why?
Numbers Needed To Treat
1
2021
7
0.040
Why?
Mobility Limitation
1
2022
68
0.040
Why?
Injections, Intravenous
2
2000
197
0.040
Why?
Pipecolic Acids
1
2001
26
0.040
Why?
Hirudin Therapy
1
2000
2
0.040
Why?
Intermittent Claudication
1
2022
121
0.040
Why?
Frailty
1
2024
208
0.040
Why?
Antineoplastic Agents, Phytogenic
1
2021
178
0.040
Why?
Antithrombins
1
2000
71
0.040
Why?
Patient Care
1
2021
120
0.040
Why?
Streptokinase
2
1997
9
0.040
Why?
Heart Valve Diseases
1
2001
151
0.040
Why?
Patient Safety
2
2013
352
0.040
Why?
Acetates
1
2000
78
0.040
Why?
Clinical Trials, Phase II as Topic
1
2019
74
0.040
Why?
Stents
2
2002
554
0.040
Why?
Animals
6
2026
38106
0.040
Why?
Cerebral Angiography
1
2019
121
0.040
Why?
Monitoring, Physiologic
1
2001
279
0.040
Why?
Heart Atria
1
2020
139
0.040
Why?
Drug Dosage Calculations
1
2019
27
0.040
Why?
MEDLINE
1
2018
20
0.040
Why?
Diagnostic Tests, Routine
1
2019
109
0.030
Why?
Sex Distribution
2
2015
382
0.030
Why?
Antibody Formation
1
1999
290
0.030
Why?
Arginine
2
2015
264
0.030
Why?
Disease-Free Survival
1
2020
778
0.030
Why?
Placebos
1
1998
192
0.030
Why?
Blood Pressure
2
2016
1765
0.030
Why?
Australia
1
2019
291
0.030
Why?
Dermatan Sulfate
1
1997
4
0.030
Why?
Pyridones
1
2020
210
0.030
Why?
Computed Tomography Angiography
1
2019
151
0.030
Why?
Global Health
1
2021
403
0.030
Why?
Alanine Transaminase
2
2011
151
0.030
Why?
Catheters, Indwelling
1
1998
94
0.030
Why?
Chondroitin Sulfates
1
1997
35
0.030
Why?
Statistics, Nonparametric
1
2018
426
0.030
Why?
Coronary Artery Bypass
1
2000
269
0.030
Why?
Health Status Disparities
1
2021
322
0.030
Why?
Hemodilution
1
1997
11
0.030
Why?
Diltiazem
1
2017
17
0.030
Why?
Blood Transfusion, Autologous
1
1997
18
0.030
Why?
Ligands
1
1999
678
0.030
Why?
Verapamil
1
2017
37
0.030
Why?
Walking
1
2022
546
0.030
Why?
Hip Prosthesis
1
1997
43
0.030
Why?
Recombinant Fusion Proteins
1
2000
663
0.030
Why?
Postoperative Period
2
2013
355
0.030
Why?
Gingivoplasty
1
1996
1
0.030
Why?
Alveoloplasty
1
1996
2
0.030
Why?
Lip
1
1996
23
0.030
Why?
Morbidity
1
2017
319
0.030
Why?
Maxillofacial Development
1
1996
20
0.030
Why?
Kidney Function Tests
1
2017
156
0.030
Why?
Phlebography
2
2009
38
0.030
Why?
Knee Prosthesis
1
1997
31
0.030
Why?
Glomerular Filtration Rate
1
2020
745
0.030
Why?
Survival Analysis
1
2000
1378
0.030
Why?
China
1
2017
280
0.030
Why?
Bone Transplantation
1
1996
91
0.030
Why?
Pyrazoles
1
2020
517
0.030
Why?
Thrombophilia
1
2016
89
0.030
Why?
Geography
1
2016
187
0.030
Why?
Cardiopulmonary Bypass
1
1997
217
0.030
Why?
Depressive Disorder
1
2018
361
0.030
Why?
Federal Government
1
2015
23
0.030
Why?
Anxiety Disorders
1
2018
354
0.030
Why?
Blood Platelets
1
1998
382
0.030
Why?
Clinical Decision-Making
1
2019
365
0.030
Why?
Death, Sudden
1
2015
26
0.030
Why?
Government Regulation
1
2015
38
0.030
Why?
Drug Industry
1
2015
49
0.030
Why?
Baltimore
1
2014
71
0.030
Why?
Communication
1
2021
980
0.030
Why?
Healthy Volunteers
1
2014
218
0.020
Why?
Area Under Curve
1
2014
335
0.020
Why?
Risk
1
2016
920
0.020
Why?
Congresses as Topic
1
2015
226
0.020
Why?
Leukemia, Promyelocytic, Acute
1
1993
8
0.020
Why?
North America
1
2014
300
0.020
Why?
Endopeptidases
1
1993
80
0.020
Why?
Aortic Valve Stenosis
1
2016
255
0.020
Why?
Hemarthrosis
1
2012
22
0.020
Why?
Neurotransmitter Agents
1
2013
84
0.020
Why?
Macromolecular Substances
2
1993
205
0.020
Why?
Piperazines
1
2015
368
0.020
Why?
Plasma
1
2014
222
0.020
Why?
Comparative Effectiveness Research
1
2013
171
0.020
Why?
Evidence-Based Medicine
1
2016
731
0.020
Why?
Pancreatitis
1
1993
146
0.020
Why?
Clinical Protocols
1
2013
282
0.020
Why?
Algorithms
1
1999
1849
0.020
Why?
Validation Studies as Topic
1
2011
23
0.020
Why?
Acenocoumarol
1
2010
1
0.020
Why?
Heart Rate
1
2015
846
0.020
Why?
Liver Function Tests
1
2011
103
0.020
Why?
Bilirubin
1
2011
101
0.020
Why?
Liver Cirrhosis
1
1993
278
0.020
Why?
Adverse Drug Reaction Reporting Systems
1
2011
81
0.020
Why?
Alkaline Phosphatase
1
2011
144
0.020
Why?
Drug Design
1
2011
180
0.020
Why?
Syndrome
2
2002
380
0.020
Why?
Patient Selection
1
2014
728
0.020
Why?
Cognition
1
2018
1292
0.020
Why?
Tomography, X-Ray Computed
1
2019
2786
0.020
Why?
Coronary Angiography
2
2001
325
0.020
Why?
Biomedical Research
1
2015
729
0.020
Why?
Amino Acid Sequence
2
1990
2092
0.020
Why?
Molecular Targeted Therapy
1
2011
447
0.020
Why?
Structure-Activity Relationship
1
1988
563
0.020
Why?
Molecular Structure
1
1988
484
0.020
Why?
Risk Reduction Behavior
1
2009
220
0.020
Why?
Immunoblotting
3
1993
294
0.020
Why?
Registries
1
2016
2400
0.020
Why?
In Vitro Techniques
1
1988
1041
0.020
Why?
Research Design
1
2013
1143
0.020
Why?
Epitopes
1
1988
479
0.010
Why?
Analysis of Variance
1
2009
1298
0.010
Why?
Blotting, Western
1
1988
1177
0.010
Why?
Models, Molecular
1
2011
1573
0.010
Why?
Leukemia, Myeloid, Acute
1
1993
702
0.010
Why?
Cross-Sectional Studies
1
2016
5899
0.010
Why?
Sensitivity and Specificity
1
2009
1998
0.010
Why?
Hemostatics
1
2003
66
0.010
Why?
Random Allocation
1
2003
366
0.010
Why?
Fibrinolysin
2
1993
20
0.010
Why?
Mice
1
2000
18297
0.010
Why?
Drug Resistance
1
2002
145
0.010
Why?
Statistics as Topic
1
2002
279
0.010
Why?
Purpura
1
2001
18
0.010
Why?
Blood Coagulation Tests
1
2001
72
0.010
Why?
Wound Healing
1
2003
354
0.010
Why?
Angina Pectoris
1
2000
76
0.010
Why?
Exanthema
1
2001
86
0.010
Why?
Diarrhea
1
2001
190
0.010
Why?
Confidence Intervals
1
2000
329
0.010
Why?
Probability
1
2000
309
0.010
Why?
Age Distribution
1
2000
399
0.010
Why?
Equipment Design
1
2001
520
0.010
Why?
Mutation
1
1990
4093
0.010
Why?
Odds Ratio
1
2000
1077
0.010
Why?
Young Adult
1
2014
14330
0.010
Why?
Hematocrit
1
1997
108
0.010
Why?
Sulfonamides
1
2001
594
0.010
Why?
Pain
1
2001
790
0.010
Why?
Health Care Costs
1
1998
423
0.010
Why?
Electrophoresis, Polyacrylamide Gel
1
1993
326
0.010
Why?
Disease Progression
1
2000
2867
0.010
Why?
Ristocetin
1
1992
1
0.010
Why?
Urokinase-Type Plasminogen Activator
1
1992
25
0.010
Why?
Length of Stay
1
1998
1358
0.010
Why?
Reference Values
1
1993
796
0.010
Why?
Oligonucleotide Probes
1
1990
48
0.010
Why?
Polymerase Chain Reaction
1
1990
1031
0.000
Why?
Base Sequence
1
1990
2123
0.000
Why?
Amino Acids
1
1990
515
0.000
Why?
Molecular Sequence Data
1
1990
2838
0.000
Why?
DNA
1
1990
1421
0.000
Why?
Berkowitz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)